Bhubaneswar, Sept. 26 -- New York: A new research adds to the growing body of evidence that patients with sufficient levels of Vitamin D are less likely to experience complications and die from Covid-19.

According to the study, published in the journal PLOS ONE, hospitalised Covid-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status) had a significantly decreased risk for adverse clinical outcomes and death.

In addition, they had lower blood levels of an inflammatory marker (C-reactive protein) and higher blood levels of lymphocytes (a type of immune cell to help fight infection)."This study provides direct evidence that vitamin D sufficiency can reduce ...